Work

Abstract 4358519: Combination Therapy with SGLT2 Inhibitors and Tafamidis Improves Outcomes More Than Tafamidis Alone in ATTR Cardiac Amyloidosis

Year: 2025

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.152.suppl_3.4358519

Authors: Nima Baba Ali, Sogol Attaripour Esfahani, Mohammed Tiseer Abbas, Fatmaelzahraa Abdelfattah, Kamal Awad, Milagros Pereyra, Isabel Scalia, Nadera Bismee, Hesham Sheashaa, Omar Ibrahim, Mahshad Razaghi, Julie Rosenthal, D Eric Steidley, Juan Farina, Chadi Ayoub, Reza Arsanjani

Institutions: Mayo Clinic, Mayo Clinic Hospital, Mayo Clinic in Arizona

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415791888

Cites:

Cited by:

Related to: